CEL-SCI Corporation ã¯ããããææçã®æ²»çã®ããã®å
ç«çæ³ã®ç ç©¶éçºã«åãçµãã§ããŸããå瀟ã®äž»åç ç©¶çšå
ç«çæ³ã¯ Multikine ã§ãé é žéšããã®æ²»çãç®çãšãã第 III çžèšåºè©Šéšãè¡ãããŠããŸããå瀟ã®ãªã¬ã³ã ãšãããŒãæåæç€ºã·ã¹ãã (LEAPS) ã¯ã现èããŠã€ã«ã¹ãå¯çè«ææçãèªå·±å
ç«çŸæ£ãã¢ã¬ã«ã®ãŒãç§»æ€æçµ¶åå¿ããããšéãããã«ããã®å
ç«ç³»ãåºæ¿ãããåèšåºã®ç¹èš±ååŸæžã¿ T 现è調ç¯ããã»ã¹ã§ããå瀟ã¯ãŸããLEAPS-H1N1-DCãé¢ç¯ãªãŠããã®æ²»çè¬åè£ã§ãã CEL-2000 ããã³ CEL-4000ãCOVID-19 ã³ãããŠã€ã«ã¹ã®æ²»çè¬åè£ã§ãã LEAPS COV-19 ãéçºããŠããŸããCEL-SCI Corporation ã¯ãLEAPS COVID-19 å
ç«çæ³ã®éçºã§ãžã§ãŒãžã¢å€§åŠã®ã¯ã¯ãã³ããã³å
ç«åŠã»ã³ã¿ãŒãšååå¥çŽãçµãã§ããŸããå瀟㯠1983 幎ã«èšç«ãããããŒãžãã¢å·ãŠã£ãŒã³ã«æ¬ç€Ÿã眮ããŠããŸãã